Dabigatran etexilate
- Level
- Commodity
- Parent
- 51131600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131663This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2E18WX195X. European Medicines Agency schedules Dabigatran etexilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20521. Dabigatran etexilate generally arises in the molecular formula C34H41N7O5. The term DABIGATRAN ETEXILATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 17, no. 2, 2003, list 49.) Most nations schedule dabigatran etexilate under HS 29333999 and SITC 51574. As of Q4 2014, DABIGATRAN ETEXILATE remains the US FDA Preferred Term for this commodity. Dabigatran etexilate bears US NLM identifiers UMLS ID C1571583 and NCI Concept Code C87480. SMILES: CCCCCCOC(=O)/N=C(\C1CCC(CC1)NCC2NC3CC(CCC3N2C)C(=O)N(CCC(=O)OCC)C4CCCCN4)/N.
Same parent
Under 51131600 · 61Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.